Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
Authors
Keywords
-
Journal
Pharmaceutics
Volume 14, Issue 1, Pages 176
Publisher
MDPI AG
Online
2022-01-12
DOI
10.3390/pharmaceutics14010176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay
- (2021) Eleni Pitsillou et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
- (2021) Vicky Mody et al. Communications Biology
- Kinetic characterization and inhibitor screening for the proteases leading to identification of drugs against SARS-CoV-2
- (2021) Chih-Jung Kuo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identifying primate ACE2 variants that confer resistance to SARS-CoV-2
- (2021) Maloyjo Joyraj Bhattacharjee et al. MOLECULAR BIOLOGY AND EVOLUTION
- Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries
- (2021) Yosef Masoudi-Sobhanzadeh et al. BRIEFINGS IN BIOINFORMATICS
- SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development
- (2021) Mandeep Kaur et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies
- (2021) Qazi Mohammad Sajid Jamal et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
- (2021) Damir Bojadzic et al. ACS Infectious Diseases
- 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
- (2021) Sho Konno et al. JOURNAL OF MEDICINAL CHEMISTRY
- BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
- (2021) Jianying Liu et al. NATURE
- Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
- (2021) Damariz Marín-Palma et al. MOLECULES
- Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs
- (2021) Athanasios A. Panagiotopoulos et al. MOLECULES
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential
- (2020) Jimin Xu et al. ACS Infectious Diseases
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
- (2020) Ran Yu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
- (2020) Vipul Kumar et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Immunoregulation with mTOR inhibitors to prevent COVID‐19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines
- (2020) Yunfeng Zheng et al. JOURNAL OF MEDICAL VIROLOGY
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
- (2020) Bhupesh Goyal et al. ACS Combinatorial Science
- Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors
- (2020) Jun He et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
- (2020) Alessandro Grottesi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune-mediated approaches against COVID-19
- (2020) Helena F. Florindo et al. Nature Nanotechnology
- Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
- (2020) Jiangdong Huo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
- (2020) Claudia Guadalupe Benítez-Cardoza et al. LIFE SCIENCES
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- DockCoV2: a drug database against SARS-CoV-2
- (2020) Ting-Fu Chen et al. NUCLEIC ACIDS RESEARCH
- Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection
- (2020) Maryam S. Al-Motawa et al. Frontiers in Pharmacology
- Crystal structure of SARS-CoV-2 papain-like protease
- (2020) Xiaopan Gao et al. Acta Pharmaceutica Sinica B
- Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches
- (2020) Mubarak A. Alamri et al. Journal of Pharmaceutical Analysis
- Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application
- (2019) Yandong Liu et al. Frontiers in Pharmacology
- CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma
- (2019) Sai Harshini Pindiprolu et al. MEDICAL HYPOTHESES
- SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection
- (2019) Nils C. Gassen et al. Nature Communications
- Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
- (2018) Marhiah C. Montoya et al. mBio
- Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases
- (2017) P. Noel Barrett et al. Expert Review of Vaccines
- AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment
- (2016) N. A. Daurio et al. CANCER RESEARCH
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway
- (2016) Valerie Le Sage et al. Viruses-Basel
- Estradiol-ERβ2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion
- (2016) Hogyoung Kim et al. Oncotarget
- Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance
- (2016) Raie T. Bekele et al. Scientific Reports
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis
- (2014) Jason Kindrachuk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
- (2014) Rolf Hilgenfeld FEBS Journal
- Comparative Assessment of Scoring Functions on an Updated Benchmark: 2. Evaluation Methods and General Results
- (2014) Yan Li et al. Journal of Chemical Information and Modeling
- The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis
- (2014) J. M. Lucas et al. Cancer Discovery
- Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
- (2012) M. Kawase et al. JOURNAL OF VIROLOGY
- Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
- (2012) Andreas Jurgeit et al. PLoS Pathogens
- Resistance to Chloroquine Unhinges Vivax Malaria Therapeutics
- (2011) J. Kevin Baird ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis
- (2011) Gu Jing et al. LABORATORY INVESTIGATION
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
- (2010) S. Matsuyama et al. JOURNAL OF VIROLOGY
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started